A 10- or 14-day Bismuth-containing Quadruple Therapy as a First-line Helicobacter pylori Eradication Therapy: A Systematic Review and Meta-analysis

A 10- or 14-day Bismuth-containing Quadruple Therapy as a First-line Helicobacter pylori Eradication Therapy: A Systematic Review and Meta-analysis

Background/Aims The eradication rate of the first-line standard triple therapy (STT) for Helicobacter pylori (H. pylori) infection has decreased since 2000; therefore, other first-line therapies are required. This study was aimed at investigating the efficacy of bismuth-containing quadruple therapy...

Full description

Bibliographic Details
Main Authors: Sung Eun Kim, Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi
Format: Article
Language:English
Published: Yong Chan Lee 2021-03-01
Series:The Korean Journal of Helicobacter and Upper Gastrointestinal Research
Subjects:
adverse effects
bismuth tripotassium dicitrate
disease eradication
meta-analysis
Online Access:http://www.helicojournal.org/upload/pdf/kjhugr-2020-0052.pdf

Internet

http://www.helicojournal.org/upload/pdf/kjhugr-2020-0052.pdf

Similar Items